Earnings ·
CVS reports Q3 EPS of $1.68 and raises full-year guidance to at least $6.98
CVSCVS HEALTH Corp
CVS Health reported third-quarter GAAP diluted earnings per share of $1.68, a significant improvement from the $3.13 loss in the prior year period which included a $5.7 billion goodwill impairment charge. Adjusted EPS came in at $2.09, up from $1.60, driven by improved performance in the Health Care Benefits segment and margin recovery efforts. Total revenues increased 5.4% to $108.4 billion. The company raised its full-year 2026 guidance, setting GAAP diluted EPS at least $6.98 (previously $6.84-$7.04), Adjusted EPS at least $8.20 (previously $7.90-$8.10), and cash flow from operations at least $15.5 billion (previously $11.5 billion). CVS Health operates as a leading health solutions company, integrating pharmacy services, retail wellness, and health insurance through its Aetna subsidiary.